Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
0.00%
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 850 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Market Cap
$97.39M
Operating Margin
-4041.72%
TTM Avg
-2020.86%
3Y Avg
-2836.09%
5Y Avg
-1938.59%
Market Cap
$97.24M
Operating Margin
-1366.43%
TTM Avg
-2706.78%
3Y Avg
-1353.39%
5Y Avg
-914.67%
Market Cap
$102.21M
Operating Margin
2.45%
TTM Avg
-2.63%
3Y Avg
-0.94%
5Y Avg
2.21%
Market Cap
$103.06M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$103.68M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$104.79M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-1310.83%
5Y Avg
-1301.48%
Market Cap
$92.33M
Operating Margin
-2.82%
TTM Avg
2.49%
3Y Avg
2.00%
5Y Avg
2.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| PolyPid Ltd. (PYPD) | $98.66M | 0.00% | 0.00% | 0.00% | 0.00% |
| Conexeu Sciences Inc. (CNXU)vs › | $97.40M | N/A | N/A | N/A | N/A |
| Milestone Pharmaceuticals Inc. (MIST)vs › | $97.39M | -4041.72% | -2020.86% | -2836.09% | -1938.59% |
| Korro Bio, Inc. (KRRO)vs › | $97.24M | -1366.43% | -2706.78% | -1353.39% | -914.67% |
| The Joint Corp. (JYNT)vs › | $102.21M | 2.45% | -2.63% | -0.94% | 2.21% |
| OnKure Therapeutics, Inc. (OKUR)vs › | $103.06M | 0.00% | 0.00% | 0.00% | 0.00% |
| Polaryx Therapeutics, Inc. Common Stock (PLYX)vs › | $103.68M | 0.00% | 0.00% | 0.00% | 0.00% |
| Anixa Biosciences, Inc. (ANIX)vs › | $104.79M | 0.00% | 0.00% | -1310.83% | -1301.48% |
| Park Dental Partners, Inc. Common Stock (PARK)vs › | $92.33M | -2.82% | 2.49% | 2.00% | 2.00% |
| Definitive Healthcare Corp. (DH)vs › | $105.20M | -8.52% | -145.19% | -110.33% | -78.53% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2013-12-31 | 0.00% |
